The historical rank and industry rank for China Pharma Holding's OCF Margin % or its related term are showing as below:
STU:XQJ'
s OCF Margin % Range Over the Past 10 Years
Min: -9.98 Med: 1.59 Max: 18.6
Current: 4.25
During the past 13 years, the highest OCF Margin % of China Pharma Holding was 18.60%. The lowest was -9.98%. And the median was 1.59%.
STU:XQJ's OCF Margin % is ranked worse than 63.34% of 963
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs STU:XQJ: 4.25
China Pharma Holding OCF Margin % Related Terms
China Pharma Holding OCF Margin % Historical Data
* Premium members only.
The historical data trend for China Pharma Holding's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:XQJ vs TXMD, RMTI, AYTU: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Pharma Holding OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's OCF Margin % distribution charts can be found below:
* The bar in red indicates where China Pharma Holding's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Pharma Holding (STU:XQJ) has a OCF Margin % of -5.64% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on China Pharma Holding and its competitors. According to the industry distribution chart, China Pharma Holding ranks #610 out of 963 companies in the Drug Manufacturers industry, placing it in the top 63.3%.
Is China Pharma Holding's OCF Margin % too high?
China Pharma Holding's current OCF Margin % is -5.64%. Based on the distribution chart, China Pharma Holding ranks #610 out of 963 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, China Pharma Holding has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does China Pharma Holding's OCF Margin % compare to TXMD and RMTI?
According to the Drug Manufacturers industry distribution chart, China Pharma Holding ranks #610 out of 963 companies for OCF Margin %. This places China Pharma Holding in the lower half of its industry. The industry median OCF Margin % is 9.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on China Pharma Holding and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Pharma Holding's current OCF Margin % is -5.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Pharma Holding stock overvalued right now?
China Pharma Holding (STU:XQJ) has a current OCF Margin % of -5.64%. The stock's GF Value™ is €10.05, compared to a current price of €26.80 — trading 166.7% above its estimated fair value. The current OCF Margin % is -5.64%. China Pharma Holding's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For China Pharma Holding (STU:XQJ), the current OCF Margin % is -5.64% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Pharma Holding (STU:XQJ) Overvalued in 2026?
Based on GuruFocus' analysis, China Pharma Holding stock appears to be overvalued.
The current stock price of €26.80 is trading 166.7% above its estimated GF Value™ of €10.05.
Key valuation signals for STU:XQJ:
OCF Margin %: -5.64%
GF Value™: €10.05 vs. price of €26.80 (166.7% above fair value)
No single metric tells the full story. See the STU:XQJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
26GF Score
Get the complete analysis for STU:XQJ
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:XQJ has been successfully added to your 
